The results indicate that the interactions between estrogen, progesterone and epidermal growth factor receptor pathways may be considered relevant targets for the treatment of hormone-dependent breast cancers," she said.
A combined approach of inhibiting both the hormones and the epidermal growth factor receptor may be beneficial for some women in treating hormone-dependent breast cancer.
Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future.
Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system.
The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.
Panitumumab is an investigational fully human monoclonal antibody that targets the epidermal growth factor receptor
(EGFr), a protein that plays an important role in cancer cell signaling.
ERBITUX is an IgG1 monoclonal antibody (IgG1 MAb) designed to inhibit the function of a molecular structure expressed on the surface of normal and tumor cells called the epidermal growth factor receptor
(EGFR, HER1, c-ErbB-1).
IMC-11F8, currently in Phase I testing in Europe, is a fully human, high-affinity antibody that blocks ligand-dependent activation of the epidermal growth factor receptor
The targets of these studies included epidermal growth factor receptor
(EGFR), vascular endothelial growth factor recptor-2 (VEGFR-2), insulin-like growth factor-1 receptor (IGF-1R), platelet-derived growth factor receptor alpha (PDGFRa), FMS-like tyrosine kinase 3 receptor (FLT3), and macrophage stimulating 1 receptor (RON), among others.
Designed to inhibit the function of the epidermal growth factor receptor
(EGFR) - a molecular structure linked to tumor growth - ERBITUX is the first and only monoclonal antibody to be approved for the treatment of head and neck cancer.
Epidermal growth factor receptors
are proteins that play an important role in cancer cell signaling.